|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
1,770,000,000 |
Market
Cap: |
278.00(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$132.51 - $182.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 560 |
Guru Rank Value : 3 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
378,241 |
461,916 |
540,416 |
831,596 |
Total Sell Value |
$67,061,426 |
$81,646,316 |
$93,320,391 |
$138,453,569 |
Total People Sold |
7 |
9 |
9 |
12 |
Total Sell Transactions |
7 |
11 |
13 |
29 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-06-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,700 |
450 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-06-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,960 |
473,187 |
|
- |
|
Severino Michael |
EVP, R&D and CSO |
|
2015-06-02 |
4 |
D |
$66.93 |
$1,444,082 |
D/D |
(21,576) |
172,909 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-05-19 |
4 |
S |
$66.00 |
$409,200 |
D/D |
(6,200) |
68,460 |
|
- |
|
Hurwich Thomas A. |
VP, Controller |
|
2015-05-19 |
4 |
OE |
$22.94 |
$142,232 |
D/D |
6,200 |
74,660 |
|
- |
|
Austin Roxanne S |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
30,552 |
|
- |
|
Burnside William H.l. |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
7,486 |
|
- |
|
Alpern Robert J |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
16,045 |
|
- |
|
Roberts Roy S |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
27,486 |
|
- |
|
Tilton Glenn F |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
26,692 |
|
- |
|
Liddy Edward M |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
12,607 |
|
- |
|
Waddell Frederick H |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
9,486 |
|
- |
|
Rapp Edward J |
Director |
|
2015-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,187 |
9,986 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-28 |
4 |
S |
$64.90 |
$537,569 |
D/D |
(8,281) |
482,147 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-28 |
4 |
S |
$64.74 |
$4,080,346 |
D/D |
(62,932) |
490,428 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-28 |
4 |
S |
$64.50 |
$6,206,473 |
D/D |
(95,970) |
554,660 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-28 |
4 |
OE |
$35.88 |
$6,296,115 |
D/D |
175,477 |
657,624 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-08 |
4 |
S |
$64.87 |
$84,331 |
D/D |
(1,300) |
496,397 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-04-08 |
4 |
S |
$64.72 |
$452,652 |
D/D |
(6,994) |
561,360 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2015-03-02 |
4 |
S |
$60.30 |
$1,507,500 |
D/D |
(25,000) |
274,116 |
|
- |
|
Richmond Timothy J. |
SVP, Human Resources |
|
2015-03-02 |
4 |
S |
$60.30 |
$742,534 |
D/D |
(12,314) |
106,954 |
|
- |
|
Gonzalez Richard A |
Chairman of the Board and CEO |
|
2015-02-28 |
4 |
D |
$60.50 |
$1,501,913 |
D/D |
(24,825) |
482,147 |
|
- |
|
Chase William J |
EVP, Chief Financial Officer |
|
2015-02-28 |
4 |
D |
$60.50 |
$495,616 |
D/D |
(8,192) |
218,028 |
|
- |
|
Saleki-Gerhardt Azita |
SVP, Operations |
|
2015-02-28 |
4 |
D |
$60.50 |
$277,816 |
D/D |
(4,592) |
99,963 |
|
- |
|
Schumacher Laura J |
EVP, Bus.Dev.,Ext.Aff.&GC |
|
2015-02-28 |
4 |
D |
$60.50 |
$503,179 |
D/D |
(8,317) |
299,116 |
|
- |
|
641 Records found
|
|
Page 24 of 26 |
|
|